Cargando…
Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration
(i) Background: Cognitive impairment in people with multiple sclerosis (MS) has been studied in relation to certain clinical variables (e.g., motor disability and disease duration) and lifestyle factors such as cognitive reserve (CR). However, only very few studies have considered the interaction of...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525733/ https://www.ncbi.nlm.nih.gov/pubmed/37753986 http://dx.doi.org/10.3390/bs13090708 |
_version_ | 1785110854949142528 |
---|---|
author | Maffezzini, Sabrina Pucci, Veronica Riccardi, Alice Montemurro, Sonia Puthenparampil, Marco Perini, Paola Rinaldi, Francesca Gallo, Paolo Arcara, Giorgio Mondini, Sara |
author_facet | Maffezzini, Sabrina Pucci, Veronica Riccardi, Alice Montemurro, Sonia Puthenparampil, Marco Perini, Paola Rinaldi, Francesca Gallo, Paolo Arcara, Giorgio Mondini, Sara |
author_sort | Maffezzini, Sabrina |
collection | PubMed |
description | (i) Background: Cognitive impairment in people with multiple sclerosis (MS) has been studied in relation to certain clinical variables (e.g., motor disability and disease duration) and lifestyle factors such as cognitive reserve (CR). However, only very few studies have considered the interaction of clinical variables and cognitive reserve in preserving the integrity of the neuropsychological profile. In this paper, we hypothesised that a higher level of CR might predict good cognitive efficiency by modulating the clinical outcome of the disease. (ii) Methods: A sample of 100 participants with MS (age range 30–74), was recruited and assessed remotely with a questionnaire to measure CR and a cognitive screening test. Data were analysed through generalized additive models. (iii) Results: We found that the model analysing the interaction between CR and disease duration, and between CR and motor disability, was able to explain a significant percentage of cognitive performance. In particular, higher levels of CR predicted a better cognitive performance despite a long disease duration, unless the motor disability was severe. (iv) Conclusion: This study highlights the crucial role of CR in modulating cognitive efficiency in people with MS. |
format | Online Article Text |
id | pubmed-10525733 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105257332023-09-28 Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration Maffezzini, Sabrina Pucci, Veronica Riccardi, Alice Montemurro, Sonia Puthenparampil, Marco Perini, Paola Rinaldi, Francesca Gallo, Paolo Arcara, Giorgio Mondini, Sara Behav Sci (Basel) Article (i) Background: Cognitive impairment in people with multiple sclerosis (MS) has been studied in relation to certain clinical variables (e.g., motor disability and disease duration) and lifestyle factors such as cognitive reserve (CR). However, only very few studies have considered the interaction of clinical variables and cognitive reserve in preserving the integrity of the neuropsychological profile. In this paper, we hypothesised that a higher level of CR might predict good cognitive efficiency by modulating the clinical outcome of the disease. (ii) Methods: A sample of 100 participants with MS (age range 30–74), was recruited and assessed remotely with a questionnaire to measure CR and a cognitive screening test. Data were analysed through generalized additive models. (iii) Results: We found that the model analysing the interaction between CR and disease duration, and between CR and motor disability, was able to explain a significant percentage of cognitive performance. In particular, higher levels of CR predicted a better cognitive performance despite a long disease duration, unless the motor disability was severe. (iv) Conclusion: This study highlights the crucial role of CR in modulating cognitive efficiency in people with MS. MDPI 2023-08-25 /pmc/articles/PMC10525733/ /pubmed/37753986 http://dx.doi.org/10.3390/bs13090708 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Maffezzini, Sabrina Pucci, Veronica Riccardi, Alice Montemurro, Sonia Puthenparampil, Marco Perini, Paola Rinaldi, Francesca Gallo, Paolo Arcara, Giorgio Mondini, Sara Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration |
title | Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration |
title_full | Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration |
title_fullStr | Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration |
title_full_unstemmed | Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration |
title_short | Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration |
title_sort | clinical profiles in multiple sclerosis: cognitive reserve and motor impairment along disease duration |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525733/ https://www.ncbi.nlm.nih.gov/pubmed/37753986 http://dx.doi.org/10.3390/bs13090708 |
work_keys_str_mv | AT maffezzinisabrina clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration AT pucciveronica clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration AT riccardialice clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration AT montemurrosonia clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration AT puthenparampilmarco clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration AT perinipaola clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration AT rinaldifrancesca clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration AT gallopaolo clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration AT arcaragiorgio clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration AT mondinisara clinicalprofilesinmultiplesclerosiscognitivereserveandmotorimpairmentalongdiseaseduration |